A Multi-Institutional Study on the Prevalence and Clinical Impact of Patient-Prosthesis Mismatch in Surgical Aortic

Lucy Nam1, Ruby Singh1, Sameer A Hirji2

  • 1Division of Cardiac Surgery, Massachusetts General Hospital, Boston, Massachusetts.

PubMed
Abstract

Insights

Prosthesis-patient mismatch (PPM) after aortic valve replacement is declining but still linked to worse outcomes. Older women face higher PPM risks, needing tailored surgical approaches.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Biomedical Engineering

Background:

  • Prosthesis-patient mismatch (PPM) negatively impacts surgical aortic valve replacement (SAVR) outcomes.
  • Limited contemporary understanding of PPM's clinical implications, trends, and predictors exists.

Purpose of the Study:

  • To investigate current trends in PPM prevalence and its association with clinical outcomes after SAVR.
  • To identify predictors of PPM, with a focus on age and sex differences.

Main Methods:

  • Multi-institutional study of 10,607 patients undergoing SAVR (2002-2023).
  • PPM assessed by effective orifice area indexed to body surface area (EOAi), with modified criteria for obesity (BMI ≥30 kg/m²).
  • Outcomes analyzed using Kaplan-Meier and multivariable analyses, stratified by age and sex.

Main Results:

  • PPM prevalence decreased from 31% to 18% over the last decade, associated with larger prostheses and increased annular enlargement.
  • PPM linked to higher 30-day mortality (OR 1.46) and reduced long-term survival.
  • Advanced age posed a greater PPM risk for women than men (OR 2.31 vs 1.66).

Conclusions:

  • Despite declining prevalence due to technical advances, PPM remains a significant predictor of adverse SAVR outcomes.
  • Older female patients exhibit a pronounced risk, necessitating targeted strategies like careful prosthesis selection and consideration of annular enlargement.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.1K
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K